Physician profile
Wei Gibler
NPI 1053546622
$709.31
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $230 · 2020: $207 · 2021: $109 · 2022: $106 · 2023: $57.41.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $32.41 · Consulting Fee: $25.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $32.41 |
| Consulting Fee | $25.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $402.13 | 2019-2021 | |
| Coopersurgical, INC. | $61.60 | 2020-2023 | Summit Doppler |
| Mayne Pharma Commercial LLC | $50.18 | 2021-2023 | |
| Pfizer INC. | $29.62 | 2020-2023 | |
| Minerva Surgical, INC | $28.11 | 2019 | |
| Merck Sharp & Dohme LLC | $24.99 | 2019 | |
| Agile Therapeutics, INC. | $21.55 | 2022 | |
| Astellas Pharma US INC | $18.34 | 2021 | |
| Scynexis, INC. | $17.90 | 2022 | |
| Myovant Sciences INC. | $15.12 | 2021 | |
| Sage Therapeutics, LLC | $14.43 | 2022 | |
| Convatec INC. | $14.27 | 2022 | |
| Exeltis, USA INC. | $11.07 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wei Gibler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.